Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-11

Clinical Trial Update: Diagnostic Efficacy and Safety of Flotufolastat F-18 Injection in Subjects With Biochemical Recurrence of Prostate Cancer [NA]

View source ↗

Summary

This document reports a clinical trial evaluating the diagnostic efficacy and safety of Flotufolastat F-18 injection for prostate cancer patients with biochemic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flotufolastat F-18 (flotufolastat F-18)

Snippet

Sponsor: Sinotau Pharmaceutical Group | Conditions: Prostate Cancer | NA | Status: RECRUITING